DYNATRONICS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DYNATRONICS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $27.39M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $32.53M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $40.61M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $44.34M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $47.80M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $53.41M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $62.57M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $64.41M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $35.76M | Sep 27, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $35.76M | Sep 27, 2017 |
| FY2017 | Jun 30, 2016 | $30.41M | Sep 27, 2017 |
| FY2016 | Jun 30, 2015 | $29.12M | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | $27.44M | Sep 29, 2015 |
| FY2014 | Jun 30, 2013 | $29.54M | Oct 28, 2014 |
| FY2013 | Jun 30, 2012 | $31.66M | Sep 30, 2013 |
| FY2012 | Jun 30, 2011 | $32.69M | Sep 28, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.01M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $7.63M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $10.15M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $10.67M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $12.89M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $15.10M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $19.17M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $20.42M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $11.51M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $10.35M | Sep 27, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($10.90M) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($2.70M) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | ($4.97M) | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | ($3.99M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $2.00M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($3.43M) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($921.7K) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($1.60M) | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | ($1.87M) | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($1.90M) | Sep 27, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.45M) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($2.27M) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | ($4.85M) | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | ($4.76M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($3.76M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($2.99M) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($796.1K) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($1.25M) | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | ($1.67M) | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($1.69M) | Sep 27, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 30, 2021 | $10.0K | Sep 23, 2021 |
| FY2021 | Jun 30, 2020 | $95.0K | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $54.0K | Sep 24, 2020 |
| FY2018 | Jun 30, 2018 | $1.19M | Sep 27, 2018 |
| FY2018 | Jun 30, 2017 | $1.08M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $1.07M | Sep 27, 2017 |
| FY2016 | Jun 30, 2015 | $927.0K | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | $992.7K | Sep 29, 2015 |
| FY2014 | Jun 30, 2013 | $1.12M | Oct 28, 2014 |
| FY2013 | Jun 30, 2012 | $1.41M | Sep 30, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.46M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $9.91M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $15.00M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $15.43M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $16.65M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $18.09M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $19.97M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $21.67M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $12.10M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $10.98M | Sep 27, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $300.6K | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($1.61M) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $371.1K | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | ($4.88M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $383.0K | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $3.09M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $325.7K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $761.8K | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | ($1.53M) | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($535.0K) | Sep 27, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $30.4K | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $243.3K | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $186.9K | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $317.8K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $146.9K | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $292.4K | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $224.1K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $242.9K | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $117.9K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $195.9K | Sep 27, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $15.44M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $25.94M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $30.06M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $35.43M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $39.14M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $37.60M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $39.63M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $42.05M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $26.06M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $15.27M | Sep 27, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $12.18M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $11.78M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $13.21M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $13.74M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $13.63M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $17.70M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $18.88M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $20.68M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $13.74M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $9.68M | Sep 27, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.26M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $14.16M | Oct 14, 2025 |
| FY2025 | Jun 30, 2023 | $16.86M | Oct 14, 2025 |
| FY2024 | Jun 30, 2022 | $21.70M | Sep 24, 2024 |
| FY2023 | Jun 30, 2021 | $25.51M | Sep 28, 2023 |
| FY2022 | Jun 30, 2020 | $19.90M | Sep 22, 2022 |
| FY2021 | Jun 30, 2019 | $20.76M | Sep 23, 2021 |
| FY2020 | Jun 30, 2018 | $21.38M | Sep 24, 2020 |
| FY2019 | Jun 30, 2017 | $12.32M | Sep 25, 2019 |
| FY2018 | Jun 30, 2016 | $5.59M | Sep 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $7.12M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $7.12M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $7.12M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $7.12M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $7.12M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $7.12M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $7.12M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $4.30M | Sep 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($40.51M) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($28.91M) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | ($25.48M) | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | ($19.82M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($15.09M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($16.35M) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($12.21M) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($10.49M) | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | ($8.01M) | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($5.67M) | Sep 27, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $326.3K | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $483.9K | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $398.8K | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | $550.1K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $6.10M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $2.22M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $155.5K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $1.60M | Sep 25, 2019 |
| FY2019 | Jun 30, 2017 | $254.7K | Sep 25, 2019 |
| FY2018 | Jun 30, 2016 | $966.2K | Sep 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 30, 2021 | $18.8K | Sep 23, 2021 |
| FY2021 | Jun 30, 2020 | $3.60M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $303.3K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $467.4K | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | $613.6K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $690.5K | Sep 27, 2017 |
| FY2016 | Jun 30, 2015 | $773.0K | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | $1.56M | Sep 29, 2015 |
| FY2014 | Jun 30, 2013 | $1.88M | Oct 28, 2014 |
| FY2013 | Jun 30, 2012 | $2.31M | Sep 30, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (1) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | (1) | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Sep 28, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (1) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | (1) | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Sep 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 10.62M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | 5.31M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | 4.04M | Sep 24, 2024 |
| FY2023 | Jun 30, 2022 | 3.64M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 17.36M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | 13.80M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | 8.42M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | 8.09M | Sep 25, 2019 |
| FY2018 | Jun 30, 2017 | 4.65M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | 2.81M | Sep 27, 2017 |